This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe
5-8 December 2022
Beurs van BerlageAmsterdam, Netherlands
BOOK NOW
Menu
BOOK NOW
Key Sessions
Miguel Forte, MD, Ph.D.
Chairperson's Opening Remarks – Where are we on the Industrial Revolution for Cell and Gene Therapies?
Bone Therapeutics
Markus Haindl
Keynote Presentation: Addressing Key Challenges Towards Industrialisation of Gene Therapies
Roche
keyboard_arrow_right

Day 2 - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search

Day 2 - CET/CEST (Cent Europe Summer, GMT+2)

search
08:00 - 09:0060 mins
Coffee and Registration
    09:00 - 09:1515 mins
    Plenary Session- Industrial Revolution of Cell and Gene Therapies
    Chairperson's Opening Remarks – Where are we on the Industrial Revolution for Cell and Gene Therapies?
    • Miguel Forte, MD, Ph.D. - CEO, Bone Therapeutics
    09:15 - 09:4530 mins
    Plenary Session- Industrial Revolution of Cell and Gene Therapies
    Keynote Presentation: Addressing Key Challenges Towards Industrialisation of Gene Therapies
    • Markus Haindl - Global Head Gene Therapy Technical Operations, Roche
    09:45 - 10:0520 mins
    Plenary Session- Industrial Revolution of Cell and Gene Therapies
    Keynote Presentation: Commercial Process Readiness for Cell & Gene Therapies: Take a Step Back and Jump Two Steps Ahead into cGMP Manufacturing
    • Ravi Vyzasatya - Head of European Process Development Laboratories, Cell & Gene Technologies, Lonza
    10:05 - 11:0055 mins
    Morning Coffee and Networking Break in Exhibition Hall
      11:00 - 11:055 mins
      Cell Therapy Manufacturing and Analytics
      Chairperson's Opening Remarks
      • Mark Farmery - Chief Development Officer, Anocca AB
      11:00 - 11:055 mins
      Gene Edited Ex Vivo Cell Therapy Manufacturing
      Chairperson's Opening Remarks
      • Miguel Forte, MD, Ph.D. - CEO, Bone Therapeutics
      11:00 - 11:055 mins
      In Vivo Gene Therapy Manufacturing
      Chairperson's Opening Remarks
      • Janneke Meulenberg - Managing Director, MeiraGTx Netherlands B.V.
      11:05 - 11:3530 mins
      Cell Therapy Manufacturing and Analytics
      Accelerating Process Development by Enabling New and Existing Technology
      • Elisaveta Todorova, - Senior Scientist, Cellular Manufacturing Technology & Innovation, TScan Therapeutics
      11:05 - 11:3530 mins
      Gene Edited Ex Vivo Cell Therapy Manufacturing
      Challenges from Clinic to Commercialisation
      • Mehul Patel - Senior Director Global Product Quality Lead, Bristol Myers Squibb
      11:05 - 11:3530 mins
      In Vivo Gene Therapy Manufacturing
      Viral Vectors - The More We Know, The More We Grow!!
      • Hemant Dhamne - Head of Process Development, King's College London
      11:35 - 12:0530 mins
      Cell Therapy Manufacturing and Analytics
      Roadmap to Enabling Cell and Gene Therapies (CGTs) in an Affordable and Accessible Format at the Point of Care
      • Malin Stridh - General Manager, Orgenesis NL
      11:35 - 12:0530 mins
      Gene Edited Ex Vivo Cell Therapy Manufacturing
      Scaling to Commercial Scale: Cord Blood Stem Cell Derived NK Cells
      • John Veluchamy - Senior Scientist, Cell and Gene Therapy Process Development, Glycostem Therapeutics
      11:35 - 12:0530 mins
      In Vivo Gene Therapy Manufacturing
      Insect Cell as a Factory (VectorY) For Scalable and Cost Effective Production Of AAV Gene Therapies
      • Pranav Puri - Sr. Scientist, VectorY
      12:05 - 12:2015 mins
      Cell Therapy Manufacturing and Analytics
      Towards automating tissue engineering: Quantum® and Quantum Flex for denovoSkinTM
      • Anna-Lena Murphy - Associate Research Manager, CUTISS AG
      12:05 - 12:2015 mins
      In Vivo Gene Therapy Manufacturing
      Adopting a QbD Mindset for Designing, Building and Validating a Commercial Gene Therapy Facility
      • Cyrill Kellerhals - Head of Manufacturing, Andelyn Biosciences
      12:20 - 12:4020 mins
      Cell Therapy Manufacturing and Analytics
      Solving Challenges of Cryopreservation Preparation through Automation
      • Yann Peytour - Field Application specialist, ScaleReady
      12:20 - 12:3515 mins
      In Vivo Gene Therapy Manufacturing
      Seamless AAV Manufacturing to the Global Gene Therapy Community
      • Goutham Ganjam - Head of AAV Manufacturing, DiNAMIQs
      12:40 - 13:0020 mins
      Networking Lunch in the Exhibition Hall
        13:00 - 14:0060 mins
        Live Labs in the Exhibition Hall
          14:00 - 14:3030 mins
          Cell Therapy Manufacturing and Analytics
          Nanoelectronics, the Key to Scalable Cell-Therapy Precision, Turnaround Time and Yield
          • Liesbet Lagae - Research Fellow & Program Director Life Sciences Technologies, imec
          14:00 - 14:3030 mins
          In Vivo Gene Therapy Manufacturing
          Viral Gene Therapy – How Can the Industry Drive Down the Cost of Goods to Better Serve the Patients?
          • Emmanuelle Cameau - Strategic Technology Partnership Leader – Cell & Gene Therapy, Pall Corporation
          14:30 - 15:0030 mins
          Cell Therapy Manufacturing and Analytics
          Quality by Design for Cell Therapy Manufacturing
          • Valters Stelmanis - Regulatory Specialist, Glycostem Therapeutics
          14:30 - 15:0030 mins
          Gene Edited Ex Vivo Cell Therapy Manufacturing
          Quality Management for RNA Cell Therapy
          • Emily English - Senior Director, Quality, Cartesian Therapeutics
          14:30 - 15:0030 mins
          In Vivo Gene Therapy Manufacturing
          Viral Control Strategy For Gene Therapy Vectors
          • Christopher Bravery, Ph.D. - Consulting Regulatory Scientist, Advbiols
          15:00 - 15:1515 mins
          Cell Therapy Manufacturing and Analytics
          QIAcuity Digital PCR: An Excellent System for Viral Vector and Impurity Quantification
          • Domenica Martorana, PhD - Scientist, R&D, QIAGEN
          15:00 - 15:3030 mins
          Gene Edited Ex Vivo Cell Therapy Manufacturing
          Novel Concept for Isolators to Manufacture ATMPs and Biologics
          • Silvia Aldi - Product Manager for Cell & Gene Therapy, SKAN AG
          15:00 - 15:3030 mins
          In Vivo Gene Therapy Manufacturing
          Integrated Solutions for Global Viral Vector Manufacture
          • Michael Baker - Senior Director Viral Gene Therapy, FUJIFILM Diosynth Biotechnologies
          15:15 - 15:3520 mins
          Cell Therapy Manufacturing and Analytics
          Deriving Clonally Derived iPSC Clones Using Advanced Instruments Cell Line Development Portfolio
          • Camilla Domeneghetti - Biology Manager – Cell Line Development, Advanced Instruments
          15:35 - 16:2045 mins
          Afternoon Coffee Break
            16:20 - 16:255 mins
            Closing Plenary Keynote
            Chairperson's Opening Remarks
              16:25 - 16:4520 mins
              Closing Plenary Keynote
              Scalable hiPSCs Manufacturing Platform for bioprinting in Sartorius Automated Stirred Tank Bioreactor Systems
              • Noushin Dianat - Manager of External Collaborations Team (CCT), Sartorius
              16:45 - 18:45120 mins
              Networking Reception
                Day 1
                NextDay 3
                Filter
                Streams
                Formats
                Choose Day